FDA approval of lecanemab: the real start of widespread amyloid PET use? - the EANM Neuroimaging Committee perspective.
Verger A, Yakushev I, Albert NL, van Berckel B, Brendel M, Cecchin D, Fernandez PA, Fraioli F, Guedj E, Morbelli S, Tolboom N, Traub-Weidinger T, Van Weehaeghe D, Barthel H.
Verger A, et al. Among authors: van weehaeghe d, van berckel b.
Eur J Nucl Med Mol Imaging. 2023 May;50(6):1553-1555. doi: 10.1007/s00259-023-06177-5.
Eur J Nucl Med Mol Imaging. 2023.
PMID: 36869178
Free PMC article.
No abstract available.